Search Within

Amanda Rachel Copeland

Formats
  1. Meeting Abstract (19)
  2. Journal Article (6)
Groups
  1. Nursing (25)
  2. Center for Hematologic Malignancies (23)
  3. Department of Medicine (23)
  4. Executive Committee, Center for Hematologic Malignancies (23)
  5. Hematologic Malignancies, Division of (23)
  6. Lymphoma (23)

More Groups

People
  1. Anas Younes (23)
  2. Andrew Zelenetz (13)
  3. Connie Batlevi (12)
  4. John Gerecitano (12)
  5. Craig Moskowitz (11)
  6. Andrew Intlekofer (9)

More People

Years
  1. 2020 (1)
  2. 2018 (2)
  3. 2017 (5)
  4. 2016 (6)
  5. 2015 (5)
  6. 2014 (4)

More Years

Publications
  1. Blood (10)
  2. Haematologica (3)
  3. Hematological Oncology (2)
  4. Journal of Clinical Oncology (2)
  5. Blood Cancer Journal (1)
  6. British Journal of Haematology (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Ferrata Storti Foundation (3)
  3. American Society of Clinical Oncology (2)
  4. Oncology Nursing Society (ONS) (2)
  5. Wiley Blackwell (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (25)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling combining DNA and RNA analysis of 112 formalin-fixed paraffin-embedded diffuse large B cell lymphoma specimens identifies a high frequency of clinically relevant genomic alterations
    Meeting Abstract

    Intlekofer, A. M.; Hilden, P.; Seshan, V. E.; Copeland, A. R.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations across different lymphoma histologies using a comprehensive next generation genomic sequencing clinical assay
    Meeting Abstract

    Batlevi, C.; Moskowitz, C. H.; Zelenetz, A. D.; Horwitz, S. M.; Palomba, L.; Gerecitano, J. F.; Copeland, A. R.; Hamlin, P.; Matasar, M. J.; Sauter, C. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genetic landscape of diffuse large B-cell lymphoma (DLBCL) using a novel diagnostic targeted sequencing platform
    Meeting Abstract

    Setoodeh, I.; Teruya-Feldstein, J.; Seshan, V.; Levine, R.; Zelenetz, A.; Palomba, L.; Moskowitz, C.; Van Den Brink, M.; Knapp, K.; Copeland, A.; more...
    Modern Pathology (2014)

    Fulltext@MSK | Save
  • A first-in-man phase 1 study of CUDC-907, a first-in-class chemically-designed dual inhibitor of PI3K and HDAC in patients with refractory or relapsed lymphoma and multiple myeloma
    Meeting Abstract

    Younes, A.; Flinn, I. W.; Oki, Y.; Copland, A.; Fattaey, A.; Lai, C. J.; Laliberte, R.; Voi, M.; Berdeja, J. G.
    Blood (2013)

    Fulltext@MSK | Save
  • Profiling genomic alterations of diffuse large B-cell lymphoma (DLBCL) at diagnosis, relapse, and transformation, using a novel clinical diagnostic targeted sequencing platform
    Meeting Abstract

    Intlekofer, A. M.; Sheshan, V. E.; Levine, R. L.; Zelenetz, A. D.; Teruya-Feldstein, J.; Dogan, A.; Palomba, M. L.; Moskowitz, C. H.; van den Brink, M. R. M.; Knapp, K. M.; more...
    Blood (2013)

    Fulltext@MSK | Save